← Back to Poly Medicure Ltd. overview
Poly Medicure Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹1,655 cr | ₹339 cr | ₹34.11 | ₹3,192 cr | ₹2,766 cr | 12.24% | 15.75% | 0.07x | 20.46% |
| FY2024 | ₹1,366 cr | ₹258 cr | ₹26.9 | ₹1,859 cr | ₹1,470 cr | 17.57% | 21.59% | 0.12x | 18.91% |
| FY2023 | ₹1,109 cr | ₹179 cr | ₹18.67 | ₹1,577 cr | ₹1,242 cr | 14.44% | 17.69% | 0.12x | 16.17% |
| FY2022 | ₹917 cr | ₹147 cr | ₹15.27 | ₹1,377 cr | ₹1,087 cr | 13.47% | 16.39% | 0.12x | 15.98% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.